Home > Healthcare > Medical Devices > Diagnostic Devices > Cystatin C Assay Market

Cystatin C Assay Market Trends

Report ID: GMI7697
Published Date: Dec 2023
Report Format: PDF

Download Free Sample

Cystatin C Assay Market Trends

The increasing geriatric population has created a larger pool of individuals at risk of kidney-related issues, making reliable and accurate renal function assessments crucial. For instance, according to the World Health Organization (WHO) estimates, the global population of individuals aged 60 years and above is anticipated to increase from 1 billion in 2020 to 1.4 billion by 2040. Cystatin C assays offer a valuable solution contributing to the growth of the market for assessing kidney function particularly in the elderly population. Additionally, advances in diagnostic technologies, such as point-of-care testing, are making cystatin C assays more accessible and convenient, ultimately improving patient care and helping clinicians make informed decisions about renal health among elderly population.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Market size for cystatin C assay was USD 269.6 million in 2023 and is expected to reach USD 522.6 billion by 2032 due to the increasing prevalence of chronic kidney diseases and in the surging need for early diagnosis, monitoring, and kidney stone management worldwide.

Cystatin C assay industry size from the kits products segment recorded USD 116.8 million in 2023 and is expected to register an appreciable CAGR from 2024-2032 owing to their prominent role in providing laboratories and healthcare facilities with convenient and ready-to-use solutions.

U.S. industry size for cystatin C assay recorded USD 102.4 million in 2023 due to the advanced healthcare infrastructure, widespread access to cutting-edge diagnostic technologies, and the increasing prevalence of chronic kidney diseases in the region.

Siemens Healthineers AG, Abbott Laboratories, Beckman Coulter (Danaher Corporation), Thermo Fisher Scientific Inc, bioM